MHR
HALO icon

Matthew Hamilton Rosenberg’s Halozyme HALO Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$37 – 885
2023
Q4 		$37 Hold
1
– – ﹤0.01% 908
2023
Q3 		$38 Hold
1
– – ﹤0.01% 920
2023
Q2 		$36 Buy
+1
New +$34 ﹤0.01% 947

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Matthew Hamilton Rosenberg's HALO Position: Q1 2024 in Review

Matthew Hamilton Rosenberg sold out of Halozyme (HALO) in Q1 2024, closing a stake of 1 share — an estimated $37 sold.

Matthew Hamilton Rosenberg first reported a position in HALO in Q2 2023 and held it in 3 quarters. The position peaked at $38 in Q3 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Matthew Hamilton Rosenberg reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 1 Halozyme share in Q1 2024, an estimated $37.
  • Matthew Hamilton Rosenberg first reported a position in Halozyme in Q2 2023 and held it in 3 quarters.
  • Matthew Hamilton Rosenberg's Halozyme position peaked at $38 in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2024, filed 22 Apr 2024.